Abstract
Adverse drug reactions (ADRs) are a public health problem in older subjects, being responsible for a significant morbidity, disability and mortality. Older subjects are more susceptible to develop ADRs mainly due to polypharmacy, multimorbidity and inappropriate prescribing. The prevention of these drug related negative events represents an important aim for physicians treating older patients. Several strategies could potentially be employed, including state of the art education of medical students and physicians concerning principles of geriatric medicine and appropriate prescription in older subjects, reduction of inappropriate drug use by means of computerized decision support systems, pharmacist involvement and comprehensive geriatric assessment, and finally the identification of at risk older patients. However, there is currently a lack of scientific evidence demonstrating that these strategies can achieve a reduction in ADRs and therefore future intervention studies should be performed to evaluate the best intervention to decrease the burden of drug related problems in the older population.
Keywords: Adverse drug reaction, comprehensive geriatric assessment, inappropriate prescription, multimorbidity, older subject, polypharmacy, prevention, prophylaxis, overdose, accentuation
Current Drug Metabolism
Title: The Prevention of Adverse Drug Reactions in Older Subjects
Volume: 12 Issue: 7
Author(s): Antonio Cherubini, Carmelinda Ruggiero, Beatrice Gasperini, Giuseppina Dell'Aquila, Maria Grazia Cupido, Elena Zampi, Elisa Zengarini, Hao Nguyen Nguyen, Rocco Serra, Andrea Corsonello and Fabrizia Lattanzio
Affiliation:
Keywords: Adverse drug reaction, comprehensive geriatric assessment, inappropriate prescription, multimorbidity, older subject, polypharmacy, prevention, prophylaxis, overdose, accentuation
Abstract: Adverse drug reactions (ADRs) are a public health problem in older subjects, being responsible for a significant morbidity, disability and mortality. Older subjects are more susceptible to develop ADRs mainly due to polypharmacy, multimorbidity and inappropriate prescribing. The prevention of these drug related negative events represents an important aim for physicians treating older patients. Several strategies could potentially be employed, including state of the art education of medical students and physicians concerning principles of geriatric medicine and appropriate prescription in older subjects, reduction of inappropriate drug use by means of computerized decision support systems, pharmacist involvement and comprehensive geriatric assessment, and finally the identification of at risk older patients. However, there is currently a lack of scientific evidence demonstrating that these strategies can achieve a reduction in ADRs and therefore future intervention studies should be performed to evaluate the best intervention to decrease the burden of drug related problems in the older population.
Export Options
About this article
Cite this article as:
Cherubini Antonio, Ruggiero Carmelinda, Gasperini Beatrice, Dell'Aquila Giuseppina, Grazia Cupido Maria, Zampi Elena, Zengarini Elisa, Nguyen Hao Nguyen, Serra Rocco, Corsonello Andrea and Lattanzio Fabrizia, The Prevention of Adverse Drug Reactions in Older Subjects, Current Drug Metabolism 2011; 12 (7) . https://dx.doi.org/10.2174/138920011796504482
DOI https://dx.doi.org/10.2174/138920011796504482 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pathophysiology of Arterial Hypertension: Insights from Pediatric Studies
Current Pediatric Reviews Therapeutic Potential of Endothelial Progenitor Cells for Cardiovascular Diseases
Current Vascular Pharmacology Critical Care Management of an Obese Asthmatic Patient: A Review
Current Respiratory Medicine Reviews Coronary CT and the Coronary Calcium Score, the Future of ED Risk Stratification?
Current Cardiology Reviews Factors Modulating Fibrates Response: Therapeutic Implications and Alternative Strategies
Endocrine, Metabolic & Immune Disorders - Drug Targets Oxidized-LDL and Paraoxonase-1 As Biomarkers of Coronary Artery Disease in Patients with Sleep-Disordered Breathing
Current Medicinal Chemistry Paving Roads for New Drugs in Oncology
Recent Patents on Anti-Cancer Drug Discovery The Use of Immortalized Cell Lines in GPCR Screening: The Good, Bad and Ugly.
Combinatorial Chemistry & High Throughput Screening Pathophysiology of Airway Colonization in Critically ill COPD Patient
Current Drug Targets Cardiovascular Disease in Patients with Diabetic Nephropathy
Current Molecular Medicine Anticancer Drug-Induced Immunomodulation and Cancer Therapeutics
Current Cancer Therapy Reviews Soluble Forms of RAGE in Human Diseases: Clinical and Therapeutical Implications
Current Medicinal Chemistry Interplay Between ACE2 and Angiotensin-(1-7) in the Regulation of Blood Pressure
Current Hypertension Reviews Milk Fat Globule Epidermal Growth Factor VIII Signaling in Arterial Wall Remodeling
Current Vascular Pharmacology Meet Our Editorial Board Member
Current Topics in Medicinal Chemistry Polyploidy: The Link Between Senescence and Cancer
Current Pharmaceutical Design GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice
Current Molecular Medicine Reversing Anticoagulant Therapy
Current Drug Discovery Technologies Tyrosine Kinases as Therapeutic Targets in BCR-ABL Negative Chronic Myeloproliferative Disorders
Current Drug Targets Assessing Medication Problems in those ≥ 65 Using the STOPP and START Criteria
Current Aging Science